SEROUS OVARIAN TUMOR
Clinical trials for SEROUS OVARIAN TUMOR explained in plain language.
Never miss a new study
Get alerted when new SEROUS OVARIAN TUMOR trials appear
Sign up with your email to follow new studies for SEROUS OVARIAN TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer: can a second round of niraparib after surgery keep tumors at bay?
Disease control Recruiting nowThis phase 2 trial is testing whether giving the drug niraparib again after surgery can help women with ovarian cancer whose disease has come back in just a few spots. About 30 participants will take niraparib pills daily until their cancer grows or side effects become too much. …
Matched conditions: SEROUS OVARIAN TUMOR
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a natural pill prevent blood clots in ovarian cancer patients?
Disease control Recruiting nowThis study tests whether a daily pill called isoquercetin, made from a plant compound, can reduce blood markers linked to clot risk in people with ovarian cancer. About 90 participants receiving chemotherapy will take either isoquercetin or a placebo for up to 6 weeks. The goal i…
Matched conditions: SEROUS OVARIAN TUMOR
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC